Shell Asset Management Co. Reduces Stake in Laboratory Co. of America Holdings
Are you interested in the latest developments in the financial world? If so, you’ll want to keep an eye on Laboratory Co. of America Holdings (NYSE:LH). This medical research company has been making waves in the investment world, with several institutional investors making significant moves in their stake in the company.
Shell Asset Management Co. recently cut its stake in Laboratory Co. of America by 36.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. This move comes after a number of other institutional investors have also been adjusting their positions in the company. Norges Bank, Allspring Global Investments Holdings LLC, Veritas Investment Partners UK Ltd., Public Sector Pension Investment Board, and M&G Plc are just a few of the major players who have recently made moves in Laboratory Co. of America.
In terms of analyst ratings, Laboratory Co. of America has been receiving mixed reviews. While some research firms have increased their price targets and given the stock a “buy” rating, others have dropped their price targets and given more neutral ratings. Overall, the stock has a consensus rating of “Moderate Buy” and an average price target of $241.29.
When it comes to the company’s financial performance, Laboratory Co. of America has been holding steady. The company recently reported quarterly earnings that beat analysts’ estimates, with a net margin of 3.52% and a return on equity of 14.68%. The company also announced a quarterly dividend, further solidifying its position in the market.
In terms of insider activity, there have been some notable transactions at Laboratory Co. of America. Several executives have sold shares of the company, with insider selling totaling over $1 million in the last ninety days. This could be a sign of confidence in the company’s future prospects, or it could be a cause for concern for investors.
Overall, Laboratory Co. of America Holdings is a company worth keeping an eye on. With a strong market capitalization, solid financial performance, and a mix of analyst ratings, there is a lot to consider when it comes to investing in this medical research company. Stay tuned for more updates on Laboratory Co. of America and other top stocks in the market.
